Stem Cell Therapy for Multiple Sclerosis
Support neuroprotection and functional recovery with MSC regenerative therapy.
Understanding Multiple Sclerosis
Multiple sclerosis (MS) is a chronic autoimmune condition in which the immune system attacks the myelin sheath, the protective covering of nerve fibers in the brain and spinal cord. This demyelination disrupts communication between the brain and body, leading to a wide range of neurological symptoms.
MS affects approximately 2.8 million people worldwide and typically presents between ages 20 and 40. The disease can follow different patterns: relapsing-remitting (RRMS), secondary progressive (SPMS), primary progressive (PPMS), and progressive-relapsing (PRMS).
Current treatments primarily focus on modifying disease progression through immunosuppressive drugs. While these can reduce relapse frequency, they do not repair existing nerve damage. Regenerative approaches using MSCs aim to support both neuroprotection and neural repair.
Common Symptoms
- Fatigue and weakness
- Numbness or tingling in limbs
- Vision problems (optic neuritis)
- Muscle spasms and stiffness
- Balance and coordination difficulties
- Cognitive changes and brain fog
- Bladder and bowel dysfunction
How MSC Therapy May Help
MSCs offer a multi-faceted approach to MS by addressing both the autoimmune component and the resulting nerve damage. Their immunomodulatory properties may help reduce the misguided immune attack on myelin, while their neurotrophic factors support nerve repair and protection.
Research shows that MSCs can cross the blood-brain barrier and migrate to areas of inflammation and demyelination. Once there, they may release factors that promote remyelination (the regrowth of the protective myelin sheath), protect existing neurons from further damage, and reduce neuroinflammation.
Wharton's Jelly MSCs are particularly promising for neurological conditions because of their high expression of neurotrophic factors such as BDNF (brain-derived neurotrophic factor) and NGF (nerve growth factor). These molecules support neuronal survival, growth, and the differentiation of neural progenitor cells.
Our Treatment Approach
Neurological Assessment
Comprehensive neurological evaluation including MRI review, disability scoring, and functional testing to establish baseline and guide treatment planning.
IV MSC Infusion Protocol
High-dose intravenous infusion of Wharton's Jelly MSCs designed to reach the central nervous system, modulate immune activity, and deliver neuroprotective factors.
Exosome Co-Therapy
Administration of MSC-derived exosomes, which carry bioactive molecules capable of crossing the blood-brain barrier to support neural repair and reduce inflammation.
Rehabilitation Support
Complementary therapies including guided physical rehabilitation, nutritional optimization, and lifestyle recommendations to maximize neurological recovery.
Expected Benefits
- May support neuroprotection and myelin repair
- May help modulate autoimmune activity
- Supports reduction of neuroinflammation
- May improve energy levels and reduce fatigue
- Promotes overall neurological function
- Supports long-term quality of life
Frequently Asked Questions About Multiple Sclerosis
Research indicates that MSCs may support remyelination by releasing neurotrophic factors that promote the growth of oligodendrocyte progenitor cells, which are responsible for producing new myelin. While complete repair of extensive damage is complex, many patients report functional improvements suggesting neural recovery.
MSC therapy has been studied across different MS subtypes. Patients with relapsing-remitting MS may see the greatest benefit, though those with progressive forms have also reported improvements. The medical team evaluates each patient individually to determine suitability and expected outcomes.
Reported improvements vary by patient but may include reduced fatigue, improved balance and coordination, better bladder control, increased strength, and enhanced cognitive clarity. Benefits typically develop progressively over 3-6 months following treatment.
Your treatment plan is coordinated with your existing care. In most cases, current MS medications can be continued alongside MSC therapy. Your BioGenesis medical team works with your neurologist to ensure a complementary approach.
Related Conditions
Ready to Explore Your Treatment Options?
Schedule a personalized consultation to discuss how MSC therapy may support your health journey.